Daiichi Sankyo Europe GmbH (Daiichi Sankyo) announced the completion of patient enrollment in the CLEAR cardiovascular outcomes trial. Designed to assess whether bempedoic acid reduces the risk of cardiovascular events in patients at high risk for cardiovascular...